Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly

Last updated: November 20, 2019
Sponsor: Restorbio Inc.
Overall Status: Trial Not Available

Phase

3

Condition

Respiratory Syncytial Virus (Rsv) Infection

Treatment

N/A

Clinical Study ID

NCT04139915
RTB-101-205
  • Ages > 65
  • All Genders

Study Summary

The purpose of this study is to determine if RTB101 prevents illness associated with respiratory tract infections in people ≥65 years of age.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Subjects must be ≥65 years of age

  • Subjects should require no or minimal assistance with self-care and activities ofdaily living. Subjects in assisted-living or long-term care residential facilitiesthat provide minimal assistance are eligible

  • Sexually active male subjects with a partner of child-bearing potential must bewilling to wear a condom while on study drug and for 1 week after stopping study drugand should not father a child in this period

Exclusion

Exclusion Criteria:

  • Subjects who are current smokers, stopped smoking ≤ 1 year prior to screening, or haveand a ≥ 10 pack year smoking history

  • Subjects with a medical history of clinically significant lung diseases (includingCOPD) other than asthma

  • Subjects with current evidence of a serious and/or unstable medical disorder

  • Subjects with unstable cardiac conditions

  • Subjects with a history of systemic autoimmune diseases

  • Subjects with Type I diabetes mellitus

  • Subjects with a history of immunodeficiency diseases, including a positive humanimmunodeficiency virus (HIV) test result

  • Infection with Hepatitis B (HBV) or Hepatitis C (HCV)

Study Design

Study Start date:
October 21, 2019
Estimated Completion Date:
November 15, 2019

Study Description

RTB-101-205 is a randomized, double-blind, placebo-controlled, multicenter, parallel-group, Phase 3 study to determine if RTB101, a selective TORC1 inhibitor, prevents illness associated with respiratory tract infections (defined as clinically symptomatic respiratory illness) in adults ≥65 years of age. This trial is being conducted in follow up to two Phase 2 trials in older adults in which RTB101 10 mg administered once daily for up to 16 weeks during winter cold and flu season was observed to reduce the incidence of respiratory illness associated with respiratory tract infections.

Connect with a study center

  • Clinical Research Facility

    Brampton, Ontario L6T 0G1
    Canada

    Site Not Available

  • Clinical Research Facility

    Toronto, Ontario M9V 4B4
    Canada

    Site Not Available

  • Clinical Research Facility

    Levis, Quebec G6W 0M5
    Canada

    Site Not Available

  • Clinical Research Facility

    Mirabel, Quebec J7J 2K8
    Canada

    Site Not Available

  • Clinical Research Facility

    Pointe-Claire, Quebec H9R 4S3
    Canada

    Site Not Available

  • Clinical Research Facility

    Quebec, G1V 4W2
    Canada

    Site Not Available

  • Clinical Research Facility

    Delitzsch, 4509
    Germany

    Site Not Available

  • Clinical Research Facility

    Essen, 45355
    Germany

    Site Not Available

  • Clinical Research Facility

    Bristol, BS37 4AX
    United Kingdom

    Site Not Available

  • Clinical Research Facility

    Chippenham, SN15 2SB
    United Kingdom

    Site Not Available

  • Clinical Research Facility

    Cornwall, PL23 1DT
    United Kingdom

    Site Not Available

  • Clinical Research Facility

    Liskeard, PL14 3XA
    United Kingdom

    Site Not Available

  • Clinical Research Facility

    Plymouth, PL5 3JB
    United Kingdom

    Site Not Available

  • Clinical Research Facility

    Poole, BH15 4JQ
    United Kingdom

    Site Not Available

  • Clinical Research Facility

    Torpoint, PL11 2TB
    United Kingdom

    Site Not Available

  • Clinical Research Facility

    Long Beach, California 90806
    United States

    Site Not Available

  • Clinical Research Facility

    Sacramento, California 95821
    United States

    Site Not Available

  • Clinical Research Facility

    Brandon, Florida 33511
    United States

    Site Not Available

  • Clinical Research Facility

    DeLand, Florida 32720
    United States

    Site Not Available

  • Clinical Research Facility

    Maitland, Florida 32751
    United States

    Site Not Available

  • Clinical Research Facility

    Stockbridge, Georgia 30281
    United States

    Site Not Available

  • Clinical Research Facility

    Augusta, Kansas 67010
    United States

    Site Not Available

  • Clinical Research Facility

    Lenexa, Kansas 66219
    United States

    Site Not Available

  • Clinical Research Facility

    Newton, Kansas 67114
    United States

    Site Not Available

  • Clinical Research Facility

    Wichita, Kansas 67205
    United States

    Site Not Available

  • Clinical Research Facility

    Methuen, Massachusetts 01844
    United States

    Site Not Available

  • Clinical Research Facility

    Chesterfield, Missouri 63017
    United States

    Site Not Available

  • Clinical Research Facility

    Saint Charles, Missouri 63301
    United States

    Site Not Available

  • Clinical Research Facility

    Saint Louis, Missouri 63141
    United States

    Site Not Available

  • Clinical Research Facility

    Omaha, Nebraska 68134
    United States

    Site Not Available

  • Clinical Research Facility

    Binghamton, New York 13901
    United States

    Site Not Available

  • Clinical Research Facility

    Endwell, New York 13760
    United States

    Site Not Available

  • Clinical Research Facility

    Rochester, New York 14609
    United States

    Site Not Available

  • Clinical Research Facility

    Cincinnati, Ohio 45242
    United States

    Site Not Available

  • Clinical Research Facility

    Oklahoma City, Oklahoma 73112
    United States

    Site Not Available

  • Clinical Research Facility

    Medford, Oregon 97504
    United States

    Site Not Available

  • Clinical Research Facility

    Goose Creek, South Carolina 29445
    United States

    Site Not Available

  • Clinical Research Facility

    Mount Pleasant, South Carolina 29464
    United States

    Site Not Available

  • Clinical Research Site

    Cedar Park, Texas 78613
    United States

    Site Not Available

  • Clinical Research Facility

    Houston, Texas 77095
    United States

    Site Not Available

  • Clinical Research Facility

    Magnolia, Texas 77355
    United States

    Site Not Available

  • Clinical Resarch Site

    Sugar Land, Texas 77478
    United States

    Site Not Available

  • Clinical Research Facility

    Tomball, Texas 77375
    United States

    Site Not Available

  • Clinical Research Facility

    Salt Lake City, Utah 84107
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.